Cargando…

Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy

Glycogen Storage Disease Type I (GSDI) is an inherited disease caused by glucose-6 phosphatase (G6Pase) deficiency, leading to a loss of endogenous glucose production and severe hypoglycemia. Moreover, most GSDI patients develop a chronic kidney disease (CKD) due to lipid accumulation in the kidney....

Descripción completa

Detalles Bibliográficos
Autores principales:	Monteillet, Laure, Labrune, Philippe, Hochuli, Michel, Do Cao, Jeremy, Tortereau, Antonin, Miliano, Alexane Cannella, Ardon-Zitoun, Carine, Duchampt, Adeline, Silva, Marine, Verzieux, Vincent, Mithieux, Gilles, Rajas, Fabienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947214/ https://www.ncbi.nlm.nih.gov/pubmed/34617103 http://dx.doi.org/10.1093/hmg/ddab297

Ejemplares similares

Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
por: Monteillet, Laure, et al.
Publicado: (2018)

The absence of hepatic glucose-6 phosphatase/ChREBP couple is incompatible with survival in mice
por: Rajas, Fabienne, et al.
Publicado: (2020)

The role of kidney in the inter-organ coordination of endogenous glucose production during fasting
por: Kaneko, Keizo, et al.
Publicado: (2018)

A caveolin-1 dependent glucose-6-phosphatase trafficking contributes to hepatic glucose production
por: Gautier-Stein, Amandine, et al.
Publicado: (2023)

Absence of Role of Dietary Protein Sensing in the Metabolic Benefits of Duodenal-Jejunal Bypass in the Mouse
por: Barataud, Aude, et al.
Publicado: (2017)

Metabolic benefits of gastric bypass surgery in the mouse: The role of fecal losses
por: Barataud, Aude, et al.
Publicado: (2019)

Glucotoxicity Induces Glucose-6-Phosphatase Catalytic Unit Expression by Acting on the Interaction of HIF-1α With CREB-Binding Protein
por: Gautier-Stein, Amandine, et al.
Publicado: (2012)

Hepatic stress associated with pathologies characterized by disturbed glucose production
por: Gjorgjieva, Monika, et al.
Publicado: (2019)

Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases
por: Pursell, Natalie, et al.
Publicado: (2018)

Glucose-6 Phosphate, a Central Hub for Liver Carbohydrate Metabolism
por: Rajas, Fabienne, et al.
Publicado: (2019)

Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels
por: Saeed, Ali, et al.
Publicado: (2020)

Control of Blood Glucose in the Absence of Hepatic Glucose Production During Prolonged Fasting in Mice: Induction of Renal and Intestinal Gluconeogenesis by Glucagon
por: Mutel, Elodie, et al.
Publicado: (2011)

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
por: Ravid, Mordchai
Publicado: (2009)

Renin–angiotensin system blockade for the risk of cancer and death
por: Shen, Jian, et al.
Publicado: (2016)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Left ventricular hypertrophy and renin-angiotensin system blockade
por: Cowan, Brett R., et al.
Publicado: (2009)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

Increased atherosclerosis in a mouse model of glycogen storage disease type 1a
por: La Rose, Anouk M., et al.
Publicado: (2022)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease
por: Cao, Jingsong, et al.
Publicado: (2021)

Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease
por: Kang, Hye-Ri, et al.
Publicado: (2019)

Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
por: Laverman, Gozewijn D., et al.
Publicado: (2011)

Retarding the progression of chronic kidney disease with renin angiotensin system blockade
por: Limesh, M., et al.
Publicado: (2012)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
por: Bloch, Michael J.
Publicado: (2020)

Renin-Angiotensin System Blockade in Acute Myocardial Infarction: Is There a Winner?
por: Lee, Hak Seung, et al.
Publicado: (2020)

Risk of lung cancer and renin–angiotensin blockade: a concise review
por: Rachow, Tobias, et al.
Publicado: (2020)

Link between Intestinal CD36 Ligand Binding and Satiety Induced by a High Protein Diet in Mice
por: Naville, Danielle, et al.
Publicado: (2012)

A link between hepatic glucose production and peripheral energy metabolism via hepatokines
por: Abdul-Wahed, Aya, et al.
Publicado: (2014)

Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System
por: Tanios, Bassem Y., et al.
Publicado: (2012)

Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics
por: Gismondi, Ronaldo Altenburg, et al.
Publicado: (2015)

The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD
por: Kim, Junghyun, et al.
Publicado: (2016)

Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection
por: Salah, Husam M., et al.
Publicado: (2020)

Effect of Renin-Angiotensin System Blockade on Mortality in Korean Hypertensive Patients with Proteinuria
por: Oh, Hyung Jung, et al.
Publicado: (2019)

Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control
por: Harindhanavudhi, Tasma, et al.
Publicado: (2011)

Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma
por: Tanaka, N, et al.
Publicado: (2012)

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
por: Makani, Harikrishna, et al.
Publicado: (2013)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
por: Feng, Yan-Huan, et al.
Publicado: (2016)

Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
por: Lennartz, David Paul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r57c6s84uenaec8sb6tvp94274